Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised phase III trial of simultaneous radiochemotherapy for locally advanced head and neck cancer
2005-003484-23Phase 3Completed
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Dec 2009
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of paclitaxel, cisplatin, fluorouracil and carboplatin in head and neck squamous cell carcinoma (HNSCC), Oral Mucosal Carcinoma, oropharyngeal squamous cell carcinoma (OPSCC) and 2 more (2 arms), sponsored by Universitätsklinikum Erlangen. Primary endpoint: Disease-free survival. Started Dec 2009; status: completed.
02
Drugs
paclitaxelcisplatinfluorouracilcarboplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)Oral Mucosal Carcinomaoropharyngeal squamous cell carcinoma (OPSCC)squamous cell carcinoma of the hypopharynxSquamous cell carcinoma of the supraglottic larynx (SCCSL)
Beyond the preview
Go deeper on 2005-003484-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003484-23.